Green Valley and International Scientists Join Hands to Fight against Alzheimer's Disease, Leading Global Endeavor with Innovation Hailing from China-Green Valley

Features

Green Valley and International Scientists Join Hands to Fight against Alzheimer's Disease, Leading Global Endeavor with Innovation Hailing from China

Date：2018-10-26

On the evening of November 26th 2018, a cocktail reception was organized by Green Valley during the 11th Clinical Trials on Alzheimer's Disease Conference. At the reception, Dr. Jeffrey Cummings, Director of the Cleveland Clinic Lou Ruvo Center for Brain Health, and Dr. Eric Reiman, Executive Director of Banner Alzheimer's Institute, among other distinguished AD drug development experts present, gathered with GV-971 R&D team, led by Dr. Meiyu Geng, Key Inventor of GV-971 and professor at Shanghai Institute of Materia Medica, to celebrate great achievements gained by this Chinese research team, and to envision a bright future where innovation hailing from China benefits patients across the whole world.

"Over the past 20 odd years, Green Valley has been committed to the development and manufacturing of carbohydrate drug, with an all-round carbohydrate drug development technology framework in place. Looking into the future, Green Valley will actively join hands with global partners so that GV-971 can be delivered to AD patients worldwide in a timely manner."-----Lv Songtao, Chairman & GM of Green Valley Pharmaceuticals.

Also present at the dinner party were, Green Valley carbohydrate drug R&D team, and core members of the Brain Precision Diagnosis and Research Platform R&D Team.

ShareTo：